SCHEMBL1132368

SCHEMBL1132368

CNC(=O)c1cc2c(Oc3ccc(N)cc3Cl)ccnc2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 5/20 0.51
▸ MET P08581 5/20 0.51
▸ MERTK Q12866 2/20 0.51
▸ KDR P35968 8/20 0.51
▸ AURKB Q96GD4 3/20 0.51
▸ AURKA O14965 2/20 0.51
▸ TEK Q02763 2/20 0.51
▸ LCK P06239 1/20 0.51
▸ PDGFRA P16234 5/20 0.49
▸ PDGFRB P09619 4/20 0.49
▸ RET P07949 3/20 0.48
▸ KIT P10721 2/20 0.48
▸ FGFR1 P11362 2/20 0.48
▸ FLT1 P17948 2/20 0.48
▸ FLT4 P35916 2/20 0.48
▸ RIPK2 O43353 1/20 0.48
▸ ERN1 O75460 1/20 0.48
▸ STK10 O94804 1/20 0.48
▸ MAP3K6 O95382 1/20 0.48
▸ ABL1 P00519 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132608 0.90 AXL (0.53) AXLMETMERTKKDRAURKB
SCHEMBL29487165 0.88 AXL (0.60) AXLMETMERTKKDRAURKB
SCHEMBL1132601 0.88 AXL (0.60) AXLMETMERTKKDRAURKB
SCHEMBL29558136 0.85 AXL (0.65) AXLMETMERTKKDRAURKB
SCHEMBL1890635 0.85 AXL (0.65) AXLMETMERTKKDRAURKB
SCHEMBL168497 0.83 PDGFRA (0.59) AXLKDRPDGFRAPDGFRBFGFR2
SCHEMBL1894568 0.83 KDR (0.60) AXLMETKDRAURKBAURKA
SCHEMBL22505692 0.83 KDR (0.60) AXLMETKDRAURKBAURKA
SCHEMBL29073410 0.82 KDR (0.56) AXLMETMERTKKDRAURKB
SCHEMBL29558086 0.81 AXL (0.51) AXLMETMERTKKDRAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2287155-B1 ACYLTHIOUREA COMPOUND OR SALT THEREOF, AND USE THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2013-07-17 — — EP disclosed
US-8304427-B2 Acylthiourea compound or salt thereof, and use thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2012-11-06 — — US disclosed
EP-2287155-A1 ACYLTHIOUREA COMPOUND OR SALT THEREOF, AND USE OF THE COMPOUND OR THE SALT Taiho Pharmaceutical Co., Ltd. (JP) 2011-02-23 — — EP disclosed
US-20110034439-A1 ACYLTHIOUREA COMPOUND OR SALT THEREOF, AND USE THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2011-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034439-A1 ACYLTHIOUREA COMPOUND OR SALT THEREOF, AND USE THEREOF MET, HGF, STAT6 AXL 568/4885MET 1/4885MERTK 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback